東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Prevention of genomic instability by...

New York University.

FindBook

Google Book

Amazon

博客來

Prevention of genomic instability by the dietary antimutagens genistein and lycopene.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Prevention of genomic instability by the dietary antimutagens genistein and lycopene./
作者:	Batoon, Audrey King.
面頁冊數:	201 p.
附註:	Adviser: Catherine B. Klein.
Contained By:	Dissertation Abstracts International69-05B.
標題:	Health Sciences, Nutrition. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3312916
ISBN:	9780549621270

Prevention of genomic instability by the dietary antimutagens genistein and lycopene.
Batoon, Audrey King.

Prevention of genomic instability by the dietary antimutagens genistein and lycopene. - 201 p.

Adviser: Catherine B. Klein.

Thesis (Ph.D.)--New York University, 2008.

This thesis investigated the activities and mechanisms that dietary antimutagens reduce the elevated spontaneous mutagenesis levels in human breast cancer cells. The putative chemopreventive agents, genistein (3.125 muM, 24 hrs) or lycopene (2 muM, 24 hrs) reduced the elevated spontaneous HPRT mutant fractions intrinsic in the breast tumor cells MCF-7 (ERalpha+), MDA-MB-468 (ERalpha-), and BT-474 (ERalpha+/-) by 31% to 49%. Coordinately, all three cell lines exhibited reduced frequencies of micronuclei. Analysis of microsatellite instability (MSI) showed that prevention of MSI at the anonymous chromosome 17 G29672 MSI marker was informative for 1-week exposures to genistein or lycopene in MCF-7 single cell clones. However, this MSI marker was not informative for MDA-MB-468 and BT-474 cells. Previously, we reported that MCF10A non-tumor breast cells pre-treated with genistein (3.125 muM and 12.5 muM, 24 hrs) or lycopene (2 muM and 20 muM, 24 hrs) prior to a low dose X-ray (0.75 Gy) exposure were protected against X-ray-induced aneuploidy. The dietarily-relevant and antimutagenic concentrations of genistein (3.125 muM, 24 hrs) or lycopene (2 muM, 24 hrs) also shows protection against X-ray induced MSI (G29672) in the non-tumor MCF10A cells. Apoptosis was investigated by flow cytometry and TUNEL assays as a possible antimuatagenic mechanism, but was not observed at the very low dietary-relevant concentrations of genistein or lycopene utilized in this study. At higher concentrations of genistein (50 muM, 48 hrs), a G2/M cell cycle shift was observed. To explore further mechanisms we found that both genistein (3.125 muM, 48 hr resupplementation for 1 week) and lycopene (2 muM, 1 week) modulate the methylation patterns of the GSTP1 tumor suppressor gene in MDA-MB-468 cells. RT-PCR studies confirm a lack of GSTP1 expression in untreated MDA-MB-468, with restoration of GSTP1 expression after genistein treatment (3.125 muM, 48 hr resupplementation for 1 week) or lycopene treatment (2 muM, 1 week). Lycopene (2 muM, 2 weeks) also modulated the methylation patterns of RARbeta2 in MCF10A cells. In summary, genistein and lycopene, at low dietarily relevant doses, attenuate the ongoing genomic instability present in tumor cells, possibly mitigating further tumor progression and metastasis.

ISBN: 9780549621270Subjects--Topical Terms:

1017801
Health Sciences, Nutrition.

Prevention of genomic instability by the dietary antimutagens genistein and lycopene.
LDR:03229nmm 2200289 a 45 001 890512
005 20101103
008 101103s2008 eng d
020 $a 9780549621270
035 $a (UMI)AAI3312916
035 $a AAI3312916
040 $a UMI $c UMI
100 1 $a Batoon, Audrey King. $3 1064459
245 1 0 $a Prevention of genomic instability by the dietary antimutagens genistein and lycopene.
300 $a 201 p.
500 $a Adviser: Catherine B. Klein.
500 $a Source: Dissertation Abstracts International, Volume: 69-05, Section: B, page: 2775.
502 $a Thesis (Ph.D.)--New York University, 2008.
520 $a This thesis investigated the activities and mechanisms that dietary antimutagens reduce the elevated spontaneous mutagenesis levels in human breast cancer cells. The putative chemopreventive agents, genistein (3.125 muM, 24 hrs) or lycopene (2 muM, 24 hrs) reduced the elevated spontaneous HPRT mutant fractions intrinsic in the breast tumor cells MCF-7 (ERalpha+), MDA-MB-468 (ERalpha-), and BT-474 (ERalpha+/-) by 31% to 49%. Coordinately, all three cell lines exhibited reduced frequencies of micronuclei. Analysis of microsatellite instability (MSI) showed that prevention of MSI at the anonymous chromosome 17 G29672 MSI marker was informative for 1-week exposures to genistein or lycopene in MCF-7 single cell clones. However, this MSI marker was not informative for MDA-MB-468 and BT-474 cells. Previously, we reported that MCF10A non-tumor breast cells pre-treated with genistein (3.125 muM and 12.5 muM, 24 hrs) or lycopene (2 muM and 20 muM, 24 hrs) prior to a low dose X-ray (0.75 Gy) exposure were protected against X-ray-induced aneuploidy. The dietarily-relevant and antimutagenic concentrations of genistein (3.125 muM, 24 hrs) or lycopene (2 muM, 24 hrs) also shows protection against X-ray induced MSI (G29672) in the non-tumor MCF10A cells. Apoptosis was investigated by flow cytometry and TUNEL assays as a possible antimuatagenic mechanism, but was not observed at the very low dietary-relevant concentrations of genistein or lycopene utilized in this study. At higher concentrations of genistein (50 muM, 48 hrs), a G2/M cell cycle shift was observed. To explore further mechanisms we found that both genistein (3.125 muM, 48 hr resupplementation for 1 week) and lycopene (2 muM, 1 week) modulate the methylation patterns of the GSTP1 tumor suppressor gene in MDA-MB-468 cells. RT-PCR studies confirm a lack of GSTP1 expression in untreated MDA-MB-468, with restoration of GSTP1 expression after genistein treatment (3.125 muM, 48 hr resupplementation for 1 week) or lycopene treatment (2 muM, 1 week). Lycopene (2 muM, 2 weeks) also modulated the methylation patterns of RARbeta2 in MCF10A cells. In summary, genistein and lycopene, at low dietarily relevant doses, attenuate the ongoing genomic instability present in tumor cells, possibly mitigating further tumor progression and metastasis.
590 $a School code: 0146.
650 4 $a Health Sciences, Nutrition. $3 1017801
650 4 $a Biology, Genetics. $3 1017730
650 4 $a Biology, Molecular. $3 1017719
690 $a 0307
690 $a 0369
690 $a 0570
710 2 0 $a New York University. $3 515735
773 0 $t Dissertation Abstracts International $g 69-05B.
790 $a 0146
790 1 0 $a Klein, Catherine B., $e advisor
791 $a Ph.D.
792 $a 2008
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3312916